IP Library Granted Patent US 8,343,936
Granted Patent B2
US 8,343,936 · App. 13/136,172 · Granted Jan 1, 2013

Antibacterial agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,936
App. No.
13/136,172
Granted
Jan 1, 2013
Kind
B2
Abstract

Described herein are novel macrolides, the preparation of novel macrolides, the use of novel macrolides for preventing, treating, or ameliorating various conditions, and the use of novel macrolides as antibacterial agents.

Claims (9)

1. A unit dosage form comprising a therapeutically effective amount of a compound of the formula

or a pharmaceutically acceptable salt thereof.

2. The unit dosage form of claim 1 wherein the compound is of the formula

3. The unit dosage form of claim 1 in the form of a tablet adapted for oral administration.

4. A method for treating a respiratory tract infection in a patient, the method comprising the step of administering to the patient a therapeutically effective amount of a compound of the formula

or a pharmaceutically acceptable salt thereof.

5. The method of claim 4 wherein the compound is of the formula

6. The method of claim 4 wherein the respiratory tract infection is pneumonia.

7. The method of claim 5 wherein the respiratory tract infection is pneumonia.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 14, 2015
From: OPTIMER PHARMACEUTICALS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036328/0122 →
CHANGE OF NAME Recorded Aug 12, 2015
From: OPTIMER PHARMACEUTICALS, INC.
To: OPTIMER PHARMACEUTICALS LLC
Reel/Frame 036333/0793 →